chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Developed symptoms of pain and redness at the site of the shingles vaccine with pain up the arm into the armpit with tenderness to touch. She has also had a low grade persistent headache since Friday night and the injection site is irritated and itching. Right arm with a 5 cm area of indurated redness that is warm to touch, no streaking redness or excoriation. Right axilla is tender to palpation and a tense cord is palpable within the anterior axilla. Keflex 500 mg BID x 10 days. Zyrtec or Claritin twice a day for 3-5 days for itching associated with a likely histamine reaction at the site.
Little spots in the body; Flu-like symptoms (runny nose, throat was hurting a little bit, light fever, shivers, felt tired); Rash around the eye, rash on wrists, back and face; Rash on the legs; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Little spots in the body), INFLUENZA LIKE ILLNESS (Flu-like symptoms (runny nose, throat was hurting a little bit, light fever, shivers, felt tired)), RASH (Rash around the eye, rash on wrists, back and face) and RASH (Rash on the legs) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced RASH MACULAR (Little spots in the body), INFLUENZA LIKE ILLNESS (Flu-like symptoms (runny nose, throat was hurting a little bit, light fever, shivers, felt tired)), RASH (Rash around the eye, rash on wrists, back and face) and RASH (Rash on the legs). On 16-Apr-2021, RASH (Rash around the eye, rash on wrists, back and face) had resolved. At the time of the report, RASH MACULAR (Little spots in the body) and INFLUENZA LIKE ILLNESS (Flu-like symptoms (runny nose, throat was hurting a little bit, light fever, shivers, felt tired)) outcome was unknown and RASH (Rash on the legs) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included high blood pressure and injection for the bones once every 2 years. Treatment details  included Benadryl.
I experienced joint pain, stiffness in hips, knees, shoulder, and neck for a month beginning 01/02/22 that has not resolved. Saw my pcp mid February, my limitary markers were off in lab work, so I was referred to rheumatologist. I was diagnosed with polymyalgia rheumatica autoimmune and prescribed prednisone 15mg daily on 4/16/22 by the rheumatologist. My symptoms are beginning to improve, but I will be needing treatment for 2 to 3 years.
unable to move right leg, tingly and numb, pins and needles, feels like a constant buzz in the leg  symptoms started with toes bottom  of foot and has progressed up to just below the right breast  has not affected breathing but has affected ability to urinate and bowel movements
Patient provided a booster. Patient was only 17 and did not qualify for a booster due to age.
felt weak; fatigue; This is a spontaneous report from a contactable nurse. A 21-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Lot number was not reported) as dose 1, single for COVID-19 immunization. The patient medical history was not reported. Concomitant medications included hydrochlorothiazide and escitalopram oxalate (LEXAPRO). Unsure when the patient received the first dose of COVID vaccine. The patient only stated she felt weak and fatigue afterwards on unspecified date. No problems with vaccines in past and no other vaccines given the same day as COVID vaccines. The outcome of the events was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Several hours after receiving Zostavax, patient ate lunch and developed trouble swallowing, was spitting up mucus.  Went to ER and E&D showed food lodged in distal esophagus with wheely non-obstructing esophageal ring.  3 days later 91/29/07) she returned to ER with diffuse chest sinus, fever blisters, nausea, and profuse diarrhea.  Barium swallow was normal except for small hiatal hernia.  Lab remarkable for AST 149 (8-50), AlT 99 (12-46), total bilirubin 2.3, alkaline phosphatase NL. Lipase 75 (16-63) seen 2/1/07 in my office.  Improved 81 symptoms-no nausea/diarrhea.  AST 22, ALT 42 (5-40), Bilirubin 0.6, Amylase Nl.  Her physician postulates passed CBD stone (through s/p cholg) I am reporting since Zostavax was given in proximity to abnormal liver tests.
arm at the injection site very hot to the touch; feels tingling down her arm; arm at the injection site hurt; felt very dizzy; had difficulty swallowing; arm a little sore; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (felt very dizzy), DYSPHAGIA (had difficulty swallowing), PAIN IN EXTREMITY (arm a little sore), INJECTION SITE WARMTH (arm at the injection site very hot to the touch) and PARAESTHESIA (feels tingling down her arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by reporter.  Concomitant products included LEVOTHYROXINE for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced DIZZINESS (felt very dizzy), DYSPHAGIA (had difficulty swallowing) and PAIN IN EXTREMITY (arm a little sore). On 27-Jan-2021, the patient experienced INJECTION SITE WARMTH (arm at the injection site very hot to the touch), PARAESTHESIA (feels tingling down her arm) and VACCINATION SITE PAIN (arm at the injection site hurt). On 13-Jan-2021, DIZZINESS (felt very dizzy), DYSPHAGIA (had difficulty swallowing) and PAIN IN EXTREMITY (arm a little sore) had resolved. At the time of the report, INJECTION SITE WARMTH (arm at the injection site very hot to the touch) had resolved, PARAESTHESIA (feels tingling down her arm) outcome was unknown and VACCINATION SITE PAIN (arm at the injection site hurt) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
After receiving the second dose, within hours after injection, I had a circular rash around site of injection about the 4 inches in circumference around the majority of my arm that was itchy for a few days but actually lasted for around 2 weeks. I was extremely fatigued. The fatigue lasted for around a month before I began to feel normal again. For a week after vaccination, I also had very bad headaches.
Cellulitis Left thigh.  Taken to ER 07/30/2003-Rocephin 1gm IV.  Seen at office 07/31/2003-repeat Rocephin 08/01/2003.  Discharge heplock.
sore arm, 2 days chills, maybe fever, from 12 pm to 5 pm day after administered other indications of an immune response, 6 - 10 pm day administered
Wrong diluent used: MA used sterile water instead of saline to dilute vaccine. No adverse symptoms or outcome for patient
Tested positive for COVID-19; Tested positive for COVID-19; This is a spontaneous report received from contactable reporter from a sales representative. The reporter is the patient.  A 23 year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 22Feb2021 (Lot number: EL3247) at the age of 22 years as dose 2, single and administration date 01Feb2021 (Lot number: EL3247) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. No covid prior vaccination. The following information was reported: COVID-19, VACCINATION FAILURE all with onset 29Dec2021, outcome recovering. Therapeutic measures were not taken as a result of covid-19, vaccination failure.  Follow-up attempts are completed. No follow-up attempts are needed. No further information is expected.
While recving flu vaxs felt "gushing" sensation from lt to rt chest & front &back neck.Chest felt like it was being filled w/H2O from a hose.Heat occurred in rt temple-size of thumb tack.Sx cont over 4 days.Tongue/lip swelled twisted to lt
Seen by MD Because of irritability, started after immunizations. Temp 102 axillary. Chest Xray clear. WBC WNL. DX; viral illness more likely pertussis rxn.
Client called on 8/26/21 and stated that her shoulder was hurting, and her upper arm was swollen. Recommended to rest it and put ice pack on it and call her PCP if no improvement. She voiced understanding.
Hives, rash, shortness of breath and chest tightness one hour after receiving vaccine. Took zantac, zyrtec, benadryl, albuterol and prednisone at home. 24 hours later all symptoms but chest tightness have resolved. Patient is declining medical care.
lymph node in base of neck on left side painful; Left shoulder stiff; Left shoulder was swollen; Lymph node in base of neck on left side very swollen; Painful to move left arm or neck to the side; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown) solution for injection via an unspecified route of administration in left arm 05Mar2021, 12:00 (at the age of 28 years old) as a single dose for COVID-19 immunisation. The patient had no history of allergies for food and drugs. Patient medical history included asthma. Concomitant medications included Montelukast sodium 10 mg daily for unknown indication. The patient has not had symptoms associated with COVID-19. Patient did not receive any other vaccine 4 weeks prior to COVID-19 vaccination. Prior to vaccination the patient was not diagnosed with COVID-19. On 11Mar2021 the patient experienced lymph node in base of neck on left side very swollen and painful. Left shoulder was swollen and stiff and painful to move left arm or neck to the side. The patient did not receive any treatment for the event. Clinical outcome of the events of pain neck, stiffness shoulder, pain arm and lymphadenopathy were unknown. Since the vaccination, has the patient was not tested for COVID-19. Information about lot/batch number cannot be obtained. No further information expected.
Patient received the Pfizer COVID-19 vaccine 3 days prior to admission, and felt weak with complaints of headache the following day, and the symptoms have since resolved. Mother mentioned that he has been complaining of intermittent midsternal chest pain that worsened after eating since the day prior to admission. She had been giving him peptobismol, thinking it was gas related pain. However, due to him persistently complaining of the pain after eating, she brought him to. She denied any fever, shortness of breath, weakness/fatigue. Of note, mother had COVID in march 2020 and she believed he might have been sick around that time as well.  Patient is still in the hospital and continues to receive pain medication and treatment for myocarditis  (NSAIDS and opioids)
Chills, fever, fatigue, muscle aches, restlessness/unable to sleep,  headache  Lasted all night and through the day
Pt. called c/o hives and itchiness.  States itchiness resolved, but now blotches at site and itchy rash all over abdomen.  Throat was scratchy, but seemed ok now.  Denies trouble breathing or swelling.  Instructed to go see her provider, go to ER is trouble breathing at all.  Pt. verbalized understanding.
chills on eve of vaccine fatigue for 24 hours headache for 24 hours covid arm (itching, warmth, a lump at injection site) which began on 03/02/2021
This spontaneous report was received from a registered nurse referring to an unspecified number of patients of unknown age. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On an unknown date the patients were vaccinated with GARDASIL (strength, dose, frequency, route of administration, lot number and expiration date were not provided) for prophylaxis, "outside the dosing schedule according to the prescribing information"; no further clarifying information was provided. No adverse effects reported. No further details provided. There was no product quality complaint (PQC) involved. This is one of two reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1706USA007464.
pretty good hardness at injection site; pretty good swelling at injection site; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE INDURATION (pretty good hardness at injection site) and VACCINATION SITE SWELLING (pretty good swelling at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE INDURATION (pretty good hardness at injection site) and VACCINATION SITE SWELLING (pretty good swelling at injection site). At the time of the report, VACCINATION SITE INDURATION (pretty good hardness at injection site) and VACCINATION SITE SWELLING (pretty good swelling at injection site) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient is in her 60's.  No relevant concomitant medication was reported.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events were not applicable.
10/13- sharp back pain, mucus build up in left nostril  10/14-10/16- sharp back pain, heavy mucus, fever & chiles, sweats, sleeplessness  10/17-10/19- developed rash (behind knees, upper back thigh, triceps area, around arm pits to upper back), heavy mucus, sleeplessness  10/20-10/27 - on and off chest pain, rash, light mucus,  sleeplessness 10/28- rash begins to fade, chest pain, heart burn throughout the night, sleeplessness  10/29-10/31- rash still fading, heartburn, chest pain, sleeplessness
Severe tremor activity in the bilateral arms and hands. Medications increased/changed to manage sx.
Headache; Chills; fever; Fatigue; muscle pain; pain in the arm of injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), CHILLS (Chills), PYREXIA (fever), FATIGUE (Fatigue) and MYALGIA (muscle pain) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), CHILLS (Chills), PYREXIA (fever), FATIGUE (Fatigue), MYALGIA (muscle pain) and VACCINATION SITE PAIN (pain in the arm of injection site). At the time of the report, HEADACHE (Headache), CHILLS (Chills), PYREXIA (fever), FATIGUE (Fatigue), MYALGIA (muscle pain) and VACCINATION SITE PAIN (pain in the arm of injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided by the reporter.
Information has been received from a published article, concerning a 14 year old patient who in October 2008, was vaccinated with MMR II (lot # not reported) at school. Between 20-OCT-2008 and 23-OCT-2008, the patient experienced weakness, periodic hot flashes, dizziness and anxiety attacks. The events required a particularly exaggerated health care response including 15 days in three different hospitals, a variety of diagnoses, and treatment with intravenous fluids, parenteral and oral steroids, antihistamines, vitamins, and diuretics. Despite the scarcity of objective findings, the staff at the regional hospital perceived the patient as seriously ill because of persistent complaints (primarily of weakness, periodic hot flashes and dizziness). Based on review of clinical information from AEFI (adverse events following immunization) reports the patient had signs and symptoms compatible with anxiety attacks with subsequent relapses. The outcome of the events was not reported. The authors considered that weakness, periodic hot flashes, dizziness and anxiety attacks were linked to the immunization sessions held at school. This is one of several reports received from the same source. Additional information has been requested.
My arm around the injection area was swollen and hot.  I had red lines and pain.  The next day the red lines became a large red rash on my arm, front, and both sides.  Used first anti-itch ointment and ibuprofen.  I stopped using the ointment and started taking benadryl and ibuprofen.  It slowly went away.  It finally was completely gone on January 24, 2021.
Pt. got shots at 9:44 am. At 2:45 PM pt started severe, relentless diarrhea and vomiting - she was vomiting bile and dry heaving and then falling asleep. Sent to hospital for admit.
About 15 minutes, post vax 1st Anthrax, pt felt nausea followed by sweating and some salivation. Blood pressure was elevated and felt somewhat dizzy. Reported vague chest pressure and tightness. Observed and given oxygen and symptoms resolved over about 1 hour.
Choking; Difficulty Swallowing; Low blood pressure; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 48-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in 2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for Covid-19 immunization. The following information was reported: CHOKING (medically significant) with onset 2022, outcome "unknown"; DYSPHAGIA (non-serious) with onset 2022, outcome "unknown", described as "Difficulty Swallowing"; HYPOTENSION (non-serious) with onset 2022, outcome "unknown", described as "Low blood pressure". The events "choking", "difficulty swallowing" and "low blood pressure" required emergency room (ER) visit. The patient underwent the following laboratory tests and procedures: Blood pressure measurement: (2022) Low. The report was not related to a study or programme. The patient states she ended up in the ER 3 days after receiving the vaccine and while in the ER, she had low blood pressure as well.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Unable to Breath, Excessive pain, Pulmonary Embolism. Resulted in Hospitalization.  No prior history of PE's.
MOP brought patient in on 3/14/19 stating noticed the reddened rash and bumps the evening before when giving patient a bath. Itchy and low grade temp at that time. Mother stated that the rash not as red in the office at that time as the evening before. No longer itchy or fevered.
pt reports on 12JUL95 & 13JUL95 rt upper arm was swollen extremely sore & painful; 13JUL95 pt used ice packs on lt upper arm; today 14MUL95 rt upper arm is still swollen & tender to touch but soreness is subsiding;pt has a routine appt w/MD
THE MODERNA COVID VACCINE WAS GIVEN OFF LABEL.  THE MANUFACTUER AND BUREAU OF IMMUNIZATIONS WERE CONTACTED AND THE PATIENT REPORTS ON ADVERSE REACTIONS.
Pt recvd 2 doses of Hep B vax; 1st dose was given JUN91 was Recombivax; 2nd dose was Engerix-B given 11JUL91; 12JUL91 p/vax pt ex h/a, nausea, shaky, & sick all over;
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. Pertinent medical history and drug reactions/allergies were not reported. In July 2012, the patient was vaccinated with a dose of ZOSTAVAX, subcutaneously (lot number, expiration date and dose were not reported). Concomitant medications were not reported. Subsequently, on 09-JUN-2016, the patient was inadvertently administered a second dose of ZOSTAVAX, subcutaneously, batch, lot number reported as L040443, expiration date: 15-JAN-2017, (dose was not reported). No adverse effects were reported. No product quality complain (PQC) was involved. No further details were provided. Additional information has been requested.
Per Patient Report - 'Blurry vision, tired eyes, blood vessles slighty(sic) protruding. Went to urgent care. Sent to ER from urgent care. Had lab work, CT, MRI, All normal results. Followed up with Doctor (sic) and optimatrist (sic) next day. All results normal. Had ultrasound of caritated (sic) arteries. Results normal."
Got the vaccine on Thursday 4/8. By Sunday 4/11, injection site swelled to side of bicep diameter, became inflamed, deep aches and pain, severe itching, small blisters. Treating it at home with standard ibuprofen, icing, and topical steroid cream.
THREE TO FOUR HOURS AFTER VACCINE PATIENT STATED THAT UNDERNEATH HER ARMPIT WAS SWOLLEN "FOUR TIMES THE SIZE". PATIENT HAD PAIN BETWEEN ARMPIT AND CHEST. SWELLING HAS SINCE DISSIPATED AND PAIN IS IMPROVING.
Fever, chills, fatigue, nausea, body aches, diarrhea, headache
01may89 pt vax 3rd Hepta B. 2 weeks later developed GBS @ was hospitalized w/ resp & lower-extremity paralysis.  treated w/ unspecified prescription drugs and recovered.
Shortness of breath; This spontaneous case was reported by a physician and describes the occurrence of DYSPNOEA (Shortness of breath) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 006M20A) for COVID-19 vaccination.     Concurrent medical conditions included Polymyalgia rheumatica. Concomitant products included LEVOTHYROXINE for an unknown indication.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DYSPNOEA (Shortness of breath). The patient was treated with PREDNISONE for Shortness of breath, at an unspecified dose and frequency. At the time of the report, DYSPNOEA (Shortness of breath) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.  Patient consequently had pulmonary and cardio clearance and everything was normal.
p/vax pt exp redness, swelling, warmth @ inj site;pt sought unspecified medical attention;
Systemic: Dizziness / Lightheadness-Mild, Systemic: Hypotension-Mild, Systemic: Weakness-Mild, Additional Details: Occurred about 2 minutes post injection. Patient felt dizzy and couldn't walk. Paramedics were called, but mother did not feel patient needed emergency service and will be monitoring her son at home.  Called 2 hours afterwards, and mother reported son is feeling much better.
CHILD'S DATE OF BIRTH WRITTEN WRONG AND AGE WRITTEN AS 12 ON CONSENT SIGNED BY PERSON IDENTIFYING AS FATHER. CHILD IDENTIFIED IN DATABASE WITH CORRECT DATE OF BIRTH CHILD TOO YOUNG FOR VACCINE IN 8/2021.
Stiffness in arm; not able to raise up very high; Redness; Fever in arm;  for 5 days.
PATIENT RECEIVED PFIZER FIRST, THEN FLU RIGHT AFTER. HE FAINTED MOMENTS AFTER SECOND VACCINE. HIS PUPILS WERE VERY DILATED. HE CAME TO WITHIN SECONDS, AND HAD SOME WATER. HE FAINTED AGAIN AND BEGAN CONVULSING. HE CAME TO WITHIN SECONDS AGAIN.